7 April 2021
Ursula von der Leyen appears secure in her job as president of the European Commission. That’s despite a troubled vaccine rollout in which delayed deliveries can cost lives and livelihoods. But preserving the status quo in Brussels also comes at a cost. Mehreen Khan of the Financial Times unpacks why the European institutions are not much interested in asking what’s gone wrong — let alone in taking the scalp of Mrs. von der Leyen. Hans Kundnani of Chatham House warns that unaddressed vaccine mishaps in Brussels — and simmering tensions over how to disburse pandemic relief funds — are storing up new troubles for the European project.
